Efficacy of Glycopyrrolate in Primary Hyperhidrosis Patients
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: Primary hyperhidrosis is a disorder of excessive sweating, which shares several features with anxiety disorders and has a negative impact on a patient’s quality of life. Oral glycopyrrolate is one of the treatments available. There are a few published studies on the use of glycopyrrolate given orally in the treatment of hyperhidrosis. Methods: Thies is study was a review of case notes in a series of 36 patients with primary hyperhidrosis. We made a comparison between the Keller’s scale score of a pre-glycopyrrolate medication group and the Keller’s scale score f a post-glycopyrrolate medication group. The Milanez de Campos score, Short Form_36 (SF-36) score, Beck Depression Inventory (BDI) score, Beck Anxiety Inventory (BAI) score, and autonomic nervous system (ANS) scale score were also compared between the two groups. Results: In the post-glycopyrrolate medication group, there were declines in Keller’s scale, and Milanez de Campos scale score and BAI score (P ＜ 0.001). In addition, there were increases in SF_36 score in the post-glycopyrrolate medication group (P = 0.03) However, no changes were seen in, BDI score and ANS score in the post-glycopyrrolate medication group (P ＜ 0.001). Conclusions: Glycopyrrolate is an effective initial method of treating primary hyperhidrosis that, reduces anxiety and improve patients’ quality of life.
Abstract
Background: Primary hyperhidrosis is a disorder of excessive sweating, which shares several features with anxiety disorders and has a negative impact on a patient’s quality of life. Oral glycopyrrolate is one of the treatments available. There are a few published studies on the use of glycopyrrolate given orally in the treatment of hyperhidrosis. Methods: Thies is study was a review of case notes in a series of 36 patients with primary hyperhidrosis. We made a comparison between the Keller’s scale score of a pre-glycopyrrolate medication group and the Keller’s scale score f a post-glycopyrrolate medication group. The Milanez de Campos score, Short Form_36 (SF-36) score, Beck Depression Inventory (BDI) score, Beck Anxiety Inventory (BAI) score, and autonomic nervous system (ANS) scale score were also compared between the two groups. Results: In the post-glycopyrrolate medication group, there were declines in Keller’s scale, and Milanez de Campos scale score and BAI score (P ＜ 0.001). In addition, there were increases in SF_36 score in the post-glycopyrrolate medication group (P = 0.03) However, no changes were seen in, BDI score and ANS score in the post-glycopyrrolate medication group (P ＜ 0.001). Conclusions: Glycopyrrolate is an effective initial method of treating primary hyperhidrosis that, reduces anxiety and improve patients’ quality of life.
참고문헌 (14)
- Henteleff HJ, "Evidence-based review of the surgical management of hyperhidrosis", Thorac Surg Clin, 18, pp.209~216 (2008)
- Klaber M, "Treating hyperhidrosis. Anticholinergic drugs were not mentioned", pp.321~703 (2000), BMJ
- Naumann M, "Botulinum toxin type A in treatment of bilateral primary axillary hyperhidrosis: randomised, parallel group, double blind, placebo controlled trial", BMJ, 323, pp.596~599 (2001)
- 김원옥, "본태성 다한증 환자에서 Glycopyrrolate의 경구 투여 효과", Korean Journal of Anesthesiology, 46(3), pp.298~301 (2004), 대한마취통증의학회
- Craven JL, "The Beck Depression Inventory as a screening device for major depression in renal dialysis patients", Int J Psychiatry Med, 18, pp.365~374 (1988)
- Leyfer OT, "Examination of the utility of the Beck Anxiety Inventory and its factors as a screener for anxiety disorders", J Anxiety Disord, 20, pp.444~458 (2006)
- McHorney CA, "The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs", Med Care, 31, pp.247~263 (1993)
- Ro KM, "Palmar hyperhidrosis: evidence of genetic transmission", J Vasc Surg, 35, pp.382~386 (2002)
- Ruchinskas R, "Hyperhidrosis and anxiety: chicken or egg?", Dermatology, 214, pp.195~196 (2007)
- Bugmann P, "Thoracoscopic sympathectomy using ultrasonic coagulating shears: a technical improvement in the treatment of palmar hyperhidrosis", Pediatr Surg Int, 18, pp.746~748 (2002)
- Reisfeld R, "One-year follow-up after thoracoscopic sympathectomy for hyperhidrosis", Ann Thorac Surg, 83, pp.358~359 (2007)
- Adams BB, "Hyperhidrosis in pediatric spinal cord injury: a case report and gabapentin therapy", J Am Acad Dermatol, 46, pp.444~446 (2002)
- Wollina U, "High-dose botulinum toxin type A therapy for axillary hyperhidrosis markedly prolongs the relapse-free interval", J Am Acad Dermatol, 46, pp.536~540 (2002)
- Ali-Melkkilä T, "Pharmacokinetics and related pharmacodynamics of anticholinergic drugs", Acta Anaesthesiol Scand, 37, pp.633~642 (1993)